Ronald Silver Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

IRWD Quotes by TradingView

Ronald Silver is Principal Accounting Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 276,809 shares of IRWD, which is worth approximately $869,180. The most recent transaction as insider was on Jan 05, 2026, when has been sold 35,416 shares (Class A Common Stock) at a price of $4.6 per share, resulting in proceeds of $162,913. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 277K
0% 3M change
74.79% 12M change
Total Value Held $869,180

Ronald Silver Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2026
SELL
Open market or private sale
$162,913 $4.6 p/Share
35,416 Reduced 11.34%
276,809 Class A Common Stock
Aug 11 2025
SELL
Open market or private sale
$2,390 $0.84 p/Share
2,846 Reduced 1.02%
276,809 Class A Common Stock
Feb 10 2025
SELL
Open market or private sale
$21,204 $1.76 p/Share
12,048 Reduced 4.13%
279,655 Class A Common Stock
Jan 27 2025
BUY
Grant, award, or other acquisition
-
133,333 Added 31.37%
291,703 Class A Common Stock
Aug 12 2024
SELL
Open market or private sale
$13,266 $4.27 p/Share
3,107 Reduced 1.92%
158,370 Class A Common Stock
Feb 12 2024
SELL
Open market or private sale
$120,517 $15.24 p/Share
7,908 Reduced 5.56%
134,264 Class A Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
27,213 Added 14.42%
161,477 Class A Common Stock
Aug 29 2023
BUY
Grant, award, or other acquisition
-
8,000 Added 5.33%
142,172 Class A Common Stock
Aug 14 2023
SELL
Open market or private sale
$19,839 $10.04 p/Share
1,976 Reduced 1.45%
134,172 Class A Common Stock
Mar 08 2023
BUY
Grant, award, or other acquisition
-
35,620 Added 20.99%
134,111 Class A Common Stock
Feb 28 2023
SELL
Open market or private sale
$34,484 $11.31 p/Share
3,049 Reduced 3.0%
98,491 Class A Common Stock
Feb 27 2023
SELL
Open market or private sale
$33,419 $11.41 p/Share
2,929 Reduced 2.8%
101,540 Class A Common Stock
Nov 21 2022
SELL
Open market or private sale
$7,883 $11.56 p/Share
682 Reduced 0.65%
104,469 Class A Common Stock
Aug 15 2022
SELL
Open market or private sale
$23,705 $11.77 p/Share
2,014 Reduced 1.88%
105,151 Class A Common Stock
May 23 2022
SELL
Open market or private sale
$1,380 $11.5 p/Share
120 Reduced 0.11%
105,073 Class A Common Stock
Mar 24 2022
SELL
Open market or private sale
$38,645 $12.75 p/Share
3,031 Reduced 2.8%
105,193 Class A Common Stock
Mar 02 2022
BUY
Grant, award, or other acquisition
-
47,013 Added 30.28%
108,224 Class A Common Stock
Feb 28 2022
SELL
Open market or private sale
$24,103 $10.77 p/Share
2,238 Reduced 3.53%
61,211 Class A Common Stock
Nov 23 2021
SELL
Open market or private sale
$16,930 $11.58 p/Share
1,462 Reduced 2.33%
61,213 Class A Common Stock
Aug 16 2021
SELL
Open market or private sale
$7,643 $13.48 p/Share
567 Reduced 0.9%
62,675 Class A Common Stock
Jul 20 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 24.03%
63,242 Class A Common Stock
RS

Ronald Silver

Principal Accounting Officer
Boston, MA

Track Institutional and Insider Activities on IRWD

Follow IRONWOOD PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IRWD